サマリー

カナダのプロバイオティクスサプリメント市場 2024-2028
カナダのプロバイオティクスサプリメント市場は2023-2028年に7575万米ドル成長し、予測期間中のCAGRは6.33%で加速すると予測されます。この調査レポートは、カナダのプロバイオティクスサプリメント市場について、市場規模や予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析など、包括的な分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。同市場は、生活習慣病に対する意識の高まり、プロバイオティクスサプリメントの認知度と利点の上昇、消化器系疾患の有病率の増加などが牽引しています。
Technavio社の調査レポートでは、カナダのプロバイオティクスサプリメント市場を以下のように分類しています：
疾患タイプ別
- 消化器系疾患
- 感染症
- その他
タイプ別
- 細菌
- 酵母
エンドユーザー別
- ヒト用プロバイオティクス
- 動物用プロバイオティクス
本調査では、今後数年間におけるカナダのプロバイオティクス・サプリメント市場の成長を促進する主な理由の一つとして、プロバイオティクス・サプリメントの集中的な研究開発を挙げている。また、体重管理製品に対する需要の増加やオンラインストアでのプロバイオティクスサプリメントの入手が可能であることも、市場の大きな需要につながる。
カナダのプロバイオティクスサプリメント市場に関する調査レポートは以下の分野をカバーしています：
- カナダのプロバイオティクスサプリメント市場規模
- カナダのプロバイオティクスサプリメント市場予測
- カナダのプロバイオティクスサプリメント市場産業分析
しっかりとしたベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに伴い、本レポートでは、American Biologics LLC、Archer Daniels Midland Co.、Biena Inc.、BioGaia AB、Biotix Care、Church and Dwight Co. Inc、CUSTOM PROBIOTICS Inc.、Genuine Health Inc.、International Flavors and Fragrances Inc.、Jamieson Wellness Inc.、Koninklijke DSM NV、Lallemand Inc.、Mars Inc.、Natural Factors Nutritional Products Ltd.、NOVA Essentials Inc.、PetLab Co.、Reckitt Benckiser Group Plc、The Clorox Co.、The Procter and Gamble Co.、Kerry Group Plc。また、カナダのプロバイオティクスサプリメント市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報が含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/probiotic-supplements-market-industry-in-canada-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Country Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market Segmentation by Disease Type
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 08: Parent market
o Exhibit 09: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 10: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 11: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 12: Chart on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 13: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 14: Chart on Canada: Year-over-year growth 2023-2028 (%)
o Exhibit 15: Data Table on Canada: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Probiotic supplements market in Canada 2018 - 2022
o Exhibit 16: Historic Market Size - Data Table on probiotic supplements market in Canada 2018 - 2022 ($ million)
o 4.2 Disease Type Segment Analysis 2018 - 2022
o Exhibit 17: Historic Market Size - Disease Type Segment 2018 - 2022 ($ million)
o 4.3 Type Segment Analysis 2018 - 2022
o Exhibit 18: Historic Market Size - Type Segment 2018 - 2022 ($ million)
o 4.4 End-user Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 20: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 21: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 23: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 24: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 25: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 26: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Disease Type
o 6.1 Market segments
o Exhibit 27: Chart on Disease Type - Market share 2023-2028 (%)
o Exhibit 28: Data Table on Disease Type - Market share 2023-2028 (%)
o 6.2 Comparison by Disease Type
o Exhibit 29: Chart on Comparison by Disease Type
o Exhibit 30: Data Table on Comparison by Disease Type
o 6.3 Gastrointestinal diseases - Market size and forecast 2023-2028
o Exhibit 31: Chart on Gastrointestinal diseases - Market size and forecast 2023-2028 ($ million)
o Exhibit 32: Data Table on Gastrointestinal diseases - Market size and forecast 2023-2028 ($ million)
o Exhibit 33: Chart on Gastrointestinal diseases - Year-over-year growth 2023-2028 (%)
o Exhibit 34: Data Table on Gastrointestinal diseases - Year-over-year growth 2023-2028 (%)
o 6.4 Infectious diseases - Market size and forecast 2023-2028
o Exhibit 35: Chart on Infectious diseases - Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Data Table on Infectious diseases - Market size and forecast 2023-2028 ($ million)
o Exhibit 37: Chart on Infectious diseases - Year-over-year growth 2023-2028 (%)
o Exhibit 38: Data Table on Infectious diseases - Year-over-year growth 2023-2028 (%)
o 6.5 Others - Market size and forecast 2023-2028
o Exhibit 39: Chart on Others - Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Data Table on Others - Market size and forecast 2023-2028 ($ million)
o Exhibit 41: Chart on Others - Year-over-year growth 2023-2028 (%)
o Exhibit 42: Data Table on Others - Year-over-year growth 2023-2028 (%)
o 6.6 Market opportunity by Disease Type
o Exhibit 43: Market opportunity by Disease Type ($ million)
o Exhibit 44: Data Table on Market opportunity by Disease Type ($ million)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 45: Chart on Type - Market share 2023-2028 (%)
o Exhibit 46: Data Table on Type - Market share 2023-2028 (%)
o 7.2 Comparison by Type
o Exhibit 47: Chart on Comparison by Type
o Exhibit 48: Data Table on Comparison by Type
o 7.3 Bacteria - Market size and forecast 2023-2028
o Exhibit 49: Chart on Bacteria - Market size and forecast 2023-2028 ($ million)
o Exhibit 50: Data Table on Bacteria - Market size and forecast 2023-2028 ($ million)
o Exhibit 51: Chart on Bacteria - Year-over-year growth 2023-2028 (%)
o Exhibit 52: Data Table on Bacteria - Year-over-year growth 2023-2028 (%)
o 7.4 Yeast - Market size and forecast 2023-2028
o Exhibit 53: Chart on Yeast - Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Data Table on Yeast - Market size and forecast 2023-2028 ($ million)
o Exhibit 55: Chart on Yeast - Year-over-year growth 2023-2028 (%)
o Exhibit 56: Data Table on Yeast - Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Type
o Exhibit 57: Market opportunity by Type ($ million)
o Exhibit 58: Data Table on Market opportunity by Type ($ million)
• 8 Market Segmentation by End-user
o 8.1 Market segments
o Exhibit 59: Chart on End-user - Market share 2023-2028 (%)
o Exhibit 60: Data Table on End-user - Market share 2023-2028 (%)
o 8.2 Comparison by End-user
o Exhibit 61: Chart on Comparison by End-user
o Exhibit 62: Data Table on Comparison by End-user
o 8.3 Human probiotics - Market size and forecast 2023-2028
o Exhibit 63: Chart on Human probiotics - Market size and forecast 2023-2028 ($ million)
o Exhibit 64: Data Table on Human probiotics - Market size and forecast 2023-2028 ($ million)
o Exhibit 65: Chart on Human probiotics - Year-over-year growth 2023-2028 (%)
o Exhibit 66: Data Table on Human probiotics - Year-over-year growth 2023-2028 (%)
o 8.4 Animal probiotics - Market size and forecast 2023-2028
o Exhibit 67: Chart on Animal probiotics - Market size and forecast 2023-2028 ($ million)
o Exhibit 68: Data Table on Animal probiotics - Market size and forecast 2023-2028 ($ million)
o Exhibit 69: Chart on Animal probiotics - Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on Animal probiotics - Year-over-year growth 2023-2028 (%)
o 8.5 Market opportunity by End-user
o Exhibit 71: Market opportunity by End-user ($ million)
o Exhibit 72: Data Table on Market opportunity by End-user ($ million)
• 9 Customer Landscape
o 9.1 Customer landscape overview
o Exhibit 73: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 74: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 75: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 76: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 77: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 78: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 79: Matrix on vendor position and classification
o 12.3 American Biologics LLC
o Exhibit 80: American Biologics LLC - Overview
o Exhibit 81: American Biologics LLC - Product / Service
o Exhibit 82: American Biologics LLC - Key offerings
o 12.4 Archer Daniels Midland Co.
o Exhibit 83: Archer Daniels Midland Co. - Overview
o Exhibit 84: Archer Daniels Midland Co. - Business segments
o Exhibit 85: Archer Daniels Midland Co. - Key offerings
o Exhibit 86: Archer Daniels Midland Co. - Segment focus
o 12.5 Biena Inc.
o Exhibit 87: Biena Inc. - Overview
o Exhibit 88: Biena Inc. - Product / Service
o Exhibit 89: Biena Inc. - Key offerings
o 12.6 BioGaia AB
o Exhibit 90: BioGaia AB - Overview
o Exhibit 91: BioGaia AB - Business segments
o Exhibit 92: BioGaia AB - Key news
o Exhibit 93: BioGaia AB - Key offerings
o Exhibit 94: BioGaia AB - Segment focus
o 12.7 Biotix Care
o Exhibit 95: Biotix Care - Overview
o Exhibit 96: Biotix Care - Product / Service
o Exhibit 97: Biotix Care - Key offerings
o 12.8 Church and Dwight Co. Inc.
o Exhibit 98: Church and Dwight Co. Inc. - Overview
o Exhibit 99: Church and Dwight Co. Inc. - Business segments
o Exhibit 100: Church and Dwight Co. Inc. - Key offerings
o Exhibit 101: Church and Dwight Co. Inc. - Segment focus
o 12.9 Genuine Health Inc.
o Exhibit 102: Genuine Health Inc. - Overview
o Exhibit 103: Genuine Health Inc. - Product / Service
o Exhibit 104: Genuine Health Inc. - Key offerings
o 12.10 International Flavors and Fragrances Inc.
o Exhibit 105: International Flavors and Fragrances Inc. - Overview
o Exhibit 106: International Flavors and Fragrances Inc. - Business segments
o Exhibit 107: International Flavors and Fragrances Inc. - Key news
o Exhibit 108: International Flavors and Fragrances Inc. - Key offerings
o Exhibit 109: International Flavors and Fragrances Inc. - Segment focus
o 12.11 Jamieson Wellness Inc.
o Exhibit 110: Jamieson Wellness Inc. - Overview
o Exhibit 111: Jamieson Wellness Inc. - Business segments
o Exhibit 112: Jamieson Wellness Inc. - Key news
o Exhibit 113: Jamieson Wellness Inc. - Key offerings
o Exhibit 114: Jamieson Wellness Inc. - Segment focus
o 12.12 Kerry Group Plc
o Exhibit 115: Kerry Group Plc - Overview
o Exhibit 116: Kerry Group Plc - Business segments
o Exhibit 117: Kerry Group Plc - Key news
o Exhibit 118: Kerry Group Plc - Key offerings
o Exhibit 119: Kerry Group Plc - Segment focus
o 12.13 Koninklijke DSM NV
o Exhibit 120: Koninklijke DSM NV - Overview
o Exhibit 121: Koninklijke DSM NV - Business segments
o Exhibit 122: Koninklijke DSM NV - Key news
o Exhibit 123: Koninklijke DSM NV - Key offerings
o Exhibit 124: Koninklijke DSM NV - Segment focus
o 12.14 Lallemand Inc.
o Exhibit 125: Lallemand Inc. - Overview
o Exhibit 126: Lallemand Inc. - Product / Service
o Exhibit 127: Lallemand Inc. - Key offerings
o 12.15 Natural Factors Nutritional Products Ltd.
o Exhibit 128: Natural Factors Nutritional Products Ltd. - Overview
o Exhibit 129: Natural Factors Nutritional Products Ltd. - Product / Service
o Exhibit 130: Natural Factors Nutritional Products Ltd. - Key offerings
o 12.16 NOVA Essentials Inc.
o Exhibit 131: NOVA Essentials Inc. - Overview
o Exhibit 132: NOVA Essentials Inc. - Product / Service
o Exhibit 133: NOVA Essentials Inc. - Key offerings
o 12.17 Reckitt Benckiser Group Plc
o Exhibit 134: Reckitt Benckiser Group Plc - Overview
o Exhibit 135: Reckitt Benckiser Group Plc - Business segments
o Exhibit 136: Reckitt Benckiser Group Plc - Key offerings
o Exhibit 137: Reckitt Benckiser Group Plc - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 138: Inclusions checklist
o Exhibit 139: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 140: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 141: Research methodology
o Exhibit 142: Validation techniques employed for market sizing
o Exhibit 143: Information sources
o 13.5 List of abbreviations
o Exhibit 144: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Country Market Characteristics
Exhibits4: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Vendor Market Positioning
Exhibits8: Parent market
Exhibits9: Market Characteristics
Exhibits10: Offerings of vendors included in the market definition
Exhibits11: Market segments
Exhibits12: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits13: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits14: Chart on Canada: Year-over-year growth 2023-2028 (%)
Exhibits15: Data Table on Canada: Year-over-year growth 2023-2028 (%)
Exhibits16: Historic Market Size - Data Table on probiotic supplements market in Canada 2018 - 2022 ($ million)
Exhibits17: Historic Market Size - Disease Type Segment 2018 - 2022 ($ million)
Exhibits18: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits20: Five forces analysis - Comparison between 2023 and 2028
Exhibits21: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits23: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits24: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits25: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits26: Chart on Market condition - Five forces 2023 and 2028
Exhibits27: Chart on Disease Type - Market share 2023-2028 (%)
Exhibits28: Data Table on Disease Type - Market share 2023-2028 (%)
Exhibits29: Chart on Comparison by Disease Type
Exhibits30: Data Table on Comparison by Disease Type
Exhibits31: Chart on Gastrointestinal diseases - Market size and forecast 2023-2028 ($ million)
Exhibits32: Data Table on Gastrointestinal diseases - Market size and forecast 2023-2028 ($ million)
Exhibits33: Chart on Gastrointestinal diseases - Year-over-year growth 2023-2028 (%)
Exhibits34: Data Table on Gastrointestinal diseases - Year-over-year growth 2023-2028 (%)
Exhibits35: Chart on Infectious diseases - Market size and forecast 2023-2028 ($ million)
Exhibits36: Data Table on Infectious diseases - Market size and forecast 2023-2028 ($ million)
Exhibits37: Chart on Infectious diseases - Year-over-year growth 2023-2028 (%)
Exhibits38: Data Table on Infectious diseases - Year-over-year growth 2023-2028 (%)
Exhibits39: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits40: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits41: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits42: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits43: Market opportunity by Disease Type ($ million)
Exhibits44: Data Table on Market opportunity by Disease Type ($ million)
Exhibits45: Chart on Type - Market share 2023-2028 (%)
Exhibits46: Data Table on Type - Market share 2023-2028 (%)
Exhibits47: Chart on Comparison by Type
Exhibits48: Data Table on Comparison by Type
Exhibits49: Chart on Bacteria - Market size and forecast 2023-2028 ($ million)
Exhibits50: Data Table on Bacteria - Market size and forecast 2023-2028 ($ million)
Exhibits51: Chart on Bacteria - Year-over-year growth 2023-2028 (%)
Exhibits52: Data Table on Bacteria - Year-over-year growth 2023-2028 (%)
Exhibits53: Chart on Yeast - Market size and forecast 2023-2028 ($ million)
Exhibits54: Data Table on Yeast - Market size and forecast 2023-2028 ($ million)
Exhibits55: Chart on Yeast - Year-over-year growth 2023-2028 (%)
Exhibits56: Data Table on Yeast - Year-over-year growth 2023-2028 (%)
Exhibits57: Market opportunity by Type ($ million)
Exhibits58: Data Table on Market opportunity by Type ($ million)
Exhibits59: Chart on End-user - Market share 2023-2028 (%)
Exhibits60: Data Table on End-user - Market share 2023-2028 (%)
Exhibits61: Chart on Comparison by End-user
Exhibits62: Data Table on Comparison by End-user
Exhibits63: Chart on Human probiotics - Market size and forecast 2023-2028 ($ million)
Exhibits64: Data Table on Human probiotics - Market size and forecast 2023-2028 ($ million)
Exhibits65: Chart on Human probiotics - Year-over-year growth 2023-2028 (%)
Exhibits66: Data Table on Human probiotics - Year-over-year growth 2023-2028 (%)
Exhibits67: Chart on Animal probiotics - Market size and forecast 2023-2028 ($ million)
Exhibits68: Data Table on Animal probiotics - Market size and forecast 2023-2028 ($ million)
Exhibits69: Chart on Animal probiotics - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on Animal probiotics - Year-over-year growth 2023-2028 (%)
Exhibits71: Market opportunity by End-user ($ million)
Exhibits72: Data Table on Market opportunity by End-user ($ million)
Exhibits73: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits74: Impact of drivers and challenges in 2023 and 2028
Exhibits75: Overview on Criticality of inputs and Factors of differentiation
Exhibits76: Overview on factors of disruption
Exhibits77: Impact of key risks on business
Exhibits78: Vendors covered
Exhibits79: Matrix on vendor position and classification
Exhibits80: American Biologics LLC - Overview
Exhibits81: American Biologics LLC - Product / Service
Exhibits82: American Biologics LLC - Key offerings
Exhibits83: Archer Daniels Midland Co. - Overview
Exhibits84: Archer Daniels Midland Co. - Business segments
Exhibits85: Archer Daniels Midland Co. - Key offerings
Exhibits86: Archer Daniels Midland Co. - Segment focus
Exhibits87: Biena Inc. - Overview
Exhibits88: Biena Inc. - Product / Service
Exhibits89: Biena Inc. - Key offerings
Exhibits90: BioGaia AB - Overview
Exhibits91: BioGaia AB - Business segments
Exhibits92: BioGaia AB - Key news
Exhibits93: BioGaia AB - Key offerings
Exhibits94: BioGaia AB - Segment focus
Exhibits95: Biotix Care - Overview
Exhibits96: Biotix Care - Product / Service
Exhibits97: Biotix Care - Key offerings
Exhibits98: Church and Dwight Co. Inc. - Overview
Exhibits99: Church and Dwight Co. Inc. - Business segments
Exhibits100: Church and Dwight Co. Inc. - Key offerings
Exhibits101: Church and Dwight Co. Inc. - Segment focus
Exhibits102: Genuine Health Inc. - Overview
Exhibits103: Genuine Health Inc. - Product / Service
Exhibits104: Genuine Health Inc. - Key offerings
Exhibits105: International Flavors and Fragrances Inc. - Overview
Exhibits106: International Flavors and Fragrances Inc. - Business segments
Exhibits107: International Flavors and Fragrances Inc. - Key news
Exhibits108: International Flavors and Fragrances Inc. - Key offerings
Exhibits109: International Flavors and Fragrances Inc. - Segment focus
Exhibits110: Jamieson Wellness Inc. - Overview
Exhibits111: Jamieson Wellness Inc. - Business segments
Exhibits112: Jamieson Wellness Inc. - Key news
Exhibits113: Jamieson Wellness Inc. - Key offerings
Exhibits114: Jamieson Wellness Inc. - Segment focus
Exhibits115: Kerry Group Plc - Overview
Exhibits116: Kerry Group Plc - Business segments
Exhibits117: Kerry Group Plc - Key news
Exhibits118: Kerry Group Plc - Key offerings
Exhibits119: Kerry Group Plc - Segment focus
Exhibits120: Koninklijke DSM NV - Overview
Exhibits121: Koninklijke DSM NV - Business segments
Exhibits122: Koninklijke DSM NV - Key news
Exhibits123: Koninklijke DSM NV - Key offerings
Exhibits124: Koninklijke DSM NV - Segment focus
Exhibits125: Lallemand Inc. - Overview
Exhibits126: Lallemand Inc. - Product / Service
Exhibits127: Lallemand Inc. - Key offerings
Exhibits128: Natural Factors Nutritional Products Ltd. - Overview
Exhibits129: Natural Factors Nutritional Products Ltd. - Product / Service
Exhibits130: Natural Factors Nutritional Products Ltd. - Key offerings
Exhibits131: NOVA Essentials Inc. - Overview
Exhibits132: NOVA Essentials Inc. - Product / Service
Exhibits133: NOVA Essentials Inc. - Key offerings
Exhibits134: Reckitt Benckiser Group Plc - Overview
Exhibits135: Reckitt Benckiser Group Plc - Business segments
Exhibits136: Reckitt Benckiser Group Plc - Key offerings
Exhibits137: Reckitt Benckiser Group Plc - Segment focus
Exhibits138: Inclusions checklist
Exhibits139: Exclusions checklist
Exhibits140: Currency conversion rates for US$
Exhibits141: Research methodology
Exhibits142: Validation techniques employed for market sizing
Exhibits143: Information sources
Exhibits144: List of abbreviations